Hans Herfarth

ORCID: 0000-0003-4268-823X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Inflammatory Bowel Disease
  • Microscopic Colitis
  • Eosinophilic Esophagitis
  • Helicobacter pylori-related gastroenterology studies
  • Diverticular Disease and Complications
  • Autoimmune and Inflammatory Disorders
  • Celiac Disease Research and Management
  • Immunodeficiency and Autoimmune Disorders
  • Immune Response and Inflammation
  • Colorectal Cancer Screening and Detection
  • Gut microbiota and health
  • Liver Diseases and Immunity
  • Gastrointestinal disorders and treatments
  • Autoimmune and Inflammatory Disorders Research
  • IL-33, ST2, and ILC Pathways
  • Colorectal Cancer Surgical Treatments
  • Gastrointestinal Bleeding Diagnosis and Treatment
  • Gastrointestinal motility and disorders
  • Pancreatitis Pathology and Treatment
  • Mycobacterium research and diagnosis
  • Immune cells in cancer
  • Clostridium difficile and Clostridium perfringens research
  • Immune Cell Function and Interaction
  • Esophageal and GI Pathology
  • Pancreatic and Hepatic Oncology Research

University of North Carolina at Chapel Hill
2016-2025

University Gastroenterology
1994-2023

Mount Sinai Hospital
2023

University of Toronto
2023

Princess Margaret Cancer Centre
2023

Cancer Research And Biostatistics
2023

Minnesota Gastroenterology
2022

Crohn's and Colitis Foundation
2021

Indiana University School of Medicine
2014-2018

Medical University of Vienna
2016

Genetic and environmental factors are important in the pathogenesis of clinical experimental chronic intestinal inflammation. We investigated influence normal luminal bacteria several groups selected bacterial strains on spontaneous gastrointestinal systemic inflammation HLA-B27 transgenic rats. Rats maintained germfree for 3-9 mo were compared with littermates conventionalized specific pathogen-free bacteria. Subsequently, rats colonized five to eight that either facultative or strictly...

10.1172/jci118878 article EN Journal of Clinical Investigation 1996-08-15

Colitis-associated cancer (CAC) is a major complication of inflammatory bowel diseases. We show that components the inflammasome are protective during acute and recurring colitis CAC in dextran sulfate sodium (DSS) azoxymethane + DSS models. Mice lacking adaptor protein PYCARD (ASC) caspase-1 demonstrate increased disease outcome, morbidity, histopathology, polyp formation. The tumor burden correlated with attenuated levels IL-1β IL-18 at site. To decipher nucleotide-binding domain,...

10.1084/jem.20100050 article EN The Journal of Experimental Medicine 2010-04-12

### 1.1 Introduction Ulcerative colitis is a life long disease arising from an interaction between genetic and environmental factors, but observed predominantly in the developed countries of world. The precise aetiology unknown therefore medical therapy to cure not yet available. Within Europe there North–South gradient, incidence appears have increased Southern developing recent years.1,2 Patients may live with considerable symptom burden despite treatment (66% describe interference work...

10.1016/j.crohns.2007.11.001 article EN Journal of Crohn s and Colitis 2008-01-20

It is well established that the intestinal microbiota plays a key role in pathogenesis of Crohn's disease (CD) and ulcerative colitis (UC) collectively referred to as inflammatory bowel (IBD). Epidemiological studies have provided strong evidence IBD patients bear increased risk for development colorectal cancer (CRC). However, impact on colitis-associated (CAC) remains largely unknown. In this study, we new model CAC using azoxymethane (AOM)-exposed, conventionalized-Il10(-/-) mice explored...

10.1371/journal.pone.0006026 article EN cc-by PLoS ONE 2009-06-23

Background & AimsWe evaluated the efficacy and safety of upadacitinib, an oral selective Janus kinase 1 inhibitor, in a randomized trial patients with Crohn's disease (CD).MethodsWe performed double-blind, phase 2 adults moderate to severe CD inadequate response or intolerance immunosuppressants tumor necrosis factor antagonists. Patients were randomly assigned (1:1:1:1:1:1) groups given placebo; 3 mg, 6 12 24 mg upadacitinib twice daily; once daily by ileocolonoscopy at weeks 16 induction...

10.1053/j.gastro.2020.01.047 article EN cc-by-nc-nd Gastroenterology 2020-02-08
Williams Turpin Sun-Ho Lee Juan A. Raygoza Garay Karen Madsen Jonathan B. Meddings and 91 more Larbi Bedrani Namita Power Osvaldo Espin‐Garcia Wei Xu Michelle I. Smith Anne M. Griffiths Paul Moayyedi Dan Turner Ernest G. Seidman A. Hillary Steinhart John K. Marshall Kevan Jacobson David Mack Hien Q. Huynh Çharles N. Bernstein Andrew D. Paterson Kenneth Croitoru Maria Abreu Paul L. Beck Çharles N. Bernstein Kenneth Croitoru Leo Dieleman Brian Feagan Anne M. Griffiths David S. Guttman Kevan Jacobson Gilaad G. Kaplan Denis O. Krause Karen Madsen John K. Marshall Paul Moayyedi Mark J. Ropeleski Ernest G. Seidman Mark S. Silverberg Scott B. Snapper Andy Stadnyk Hillary Steinhart Michael G. Surette Dan Turner Thomas D. Walters Bruce A. Vallance Guy Aumais Alain Bitton Maria Cino Jeff Critch Lee A. Denson Colette Deslandres Wael El‐Matary Hans Herfarth Peter Higgins Hien Q. Huynh Jeff Hyams David Mack Jerry McGrath Anthony Otley Remo Panancionne Guy Aumais Robert N. Baldassano Çharles N. Bernstein Maria Cino Lee A. Denson Colette Deslandres Wael El‐Matary Anne M. Griffiths Charlotte Hedin Hans Herfarth Peter Higgins Séamus Hussey Hien Hyams Kevan Jacobson David J. Keljo David Kevans Charlie W. Lees David Mack John K. Marshall Jerry McGrath Sanjay K. Murthy Anthony Otley Remo Panaccione Nimisha Parekh Sophie Plamondon Graham Radford-Smith Mark J. Ropeleski Joel R. Rosh David T. Rubin Michael Schultz Ernest G. Seidman Corey A. Siegel Scott B. Snapper Hillary Steinhart Dan Turner

10.1053/j.gastro.2020.08.005 article EN Gastroenterology 2020-08-10
Bruce E. Sands Peter M. Irving Timothy Hoops James Izanec Long-Long Gao and 95 more Christopher Gasink Andrew Greenspan Matthieu Allez Silvio Danese Stephen B. Hanauer Vipul Jairath Tanja Kuehbacher James D. Lewis Edward V. Loftus Emese Mihály Remo Panaccione Ellen Scherl О. Б. Щукина William J. Sandborn Anita Afzali Lilia Aitova Xavier Aldeguer i Mante Matthieu Allez I Altorjay Federico Argüelles‐Arias Alessandro Armuzzi Monika Augustyn Mauro Bafutto Jesús Barrio Jakob Begun Clint Behrend Geert Bezemer Guillaume Bonnaud Marija Branković Ik Jang Byung Xavier Calvet Karen A. Chachu Júlio Maria Fonseca Chebli Jae Hee Cheon Halina Cichoż‐Lach Larry Clark Fraser Cummings Kunal Dalal Silvio Danese Nanne K.H. de Boer Maria de Lourdes Abreu Ferrari Étienne Désilets Predrag Dugalić George Duvall Olga Fedorishina Rafał Filip Cristina Flores Ronald Fogel James Fon Michael Frankel Keith Friedenberg Walter Fries Vassileva Galina Piotr Gietka Rishi Goel Peter Hasselblatt Hans Herfarth László Herszényi Pieter Hindryckx Frank Hoentjen Carmen Horjus Talabur Horje Satish Iduru Peter M. Irving Robert J. Isfort Vipul Jairath Michael Jones Dilara Kalimullina Jeffry Katz Manreet Kaur Sunil K Khurana Joo Sung Kim Young‐Ho Kim D Kleczkowski Slavko Knezevic Aaron Knoll Louis Y Korman Iskren Kotzev Andrey Kulyapin Kang‐Moon Lee Desiree Leemreis Jarosław Leszczyszyn Jimmy K. Limdi Jack J. Lissauer Edward V. Loftus Ewa Małecka‐Panas John K. Marshall Emese Mihály Lukáš Milan Giovanni Monteleone Aleksandar Nagorni Danuta Owczarek Nichole Palekar Remo Panaccione Young Soo Park Sang Hyoung Park

10.1016/s0140-6736(22)00688-2 article EN The Lancet 2022-06-01
Williams Turpin Mei Dong Gila Sasson Juan A. Raygoza Garay Osvaldo Espin‐Garcia and 95 more Sun-Ho Lee Anna Neustaeter Michelle I. Smith Haim Leibovitzh David S. Guttman Ashleigh Goethel Anne M. Griffiths Hien Q. Huynh Levinus A. Dieleman Remo Panaccione A. Hillary Steinhart Mark S. Silverberg Guy Aumais Kevan Jacobson David R. Mack Sanjay K. Murthy John K. Marshall Çharles N. Bernstein Maria T. Abreu Paul Moayyedi Andrew D. Paterson Wei Xu Kenneth Croitoru Maria Abreu Paul L. Beck Çharles N. Bernstein Kenneth Croitoru Leo Dieleman Brian Feagan Anne M. Griffiths David S. Guttman Kevan Jacobson Gilaad G. Kaplan Denis O. Krause Karen Madsen John K. Marshall Paul Moayyedi Mark J. Ropeleski Ernest G. Seidman Mark S. Silverberg Scott B. Snapper Andy Stadnyk Hillary Steinhart Michael G. Surette Dan Turner T D Walters Bruce A. Vallance Guy Aumais Alain Bitton Maria Cino Jeff Critch Lee A. Denson Colette Deslandres Wael El‐Matary Hans Herfarth Peter Higgins Hien Q. Huynh Jeff Hyams David R. Mack Jerry McGrath Anthony Otley Remo Panancionne Guy Aumais Robert N. Baldassano Çharles N. Bernstein Lee A. Denson Colette Deslandres Wael El‐Matary Anne M. Griffiths Charlotte Hedin Hans Herfarth Peter Higgins Séamus Hussey Hien Hyams Kevan Jacobson David J. Keljo David Kevans Charlie W. Lees David R. Mack John K. Marshall Jerry McGrath Sanjay K. Murthy Anthony Otley Remo Panaccione Nimisha Parekh Sophie Plamondon Graham Radford-Smith Mark J. Ropeleski Joel R. Rosh David T. Rubin Michael Schultz Ernest G. Seidman Corey A. Siegel Scott B. Snapper Hillary Steinhart

10.1053/j.gastro.2022.05.037 article EN Gastroenterology 2022-05-26

Experimental studies have shown that luminal antigens are involved in chronic intestinal inflammatory disorders such as Crohn's disease and ulcerative colitis. Alteration of the microflora by antibiotic or probiotic therapy may induce maintain remission. The aim this randomized, placebo-controlled trial was to determine effect oral Lactobacillus GG (L. GG) medically induced Eleven patients with moderate active were enrolled receive either L. (2 × 109 CFU/day) placebo for six months. All...

10.1186/1471-230x-4-5 article EN cc-by BMC Gastroenterology 2004-03-15

Abstract Articular adipose tissue is a ubiquitous component of human joints, but its local functions are largely unknown. Because recent studies revealed several links between tissue, adipocytokines, and arthritis, we investigated the expression adipocytokine adiponectin functional role in articular synovium patients with different arthritides. In contrast to protective endocrinological vascular diseases, was found be involved key pathways inflammation matrix degradation joint. The effects...

10.4049/jimmunol.176.7.4468 article EN The Journal of Immunology 2006-04-01

Anemia is a frequent complication in patients with inflammatory bowel disease (IBD). The optimal route for iron supplementation to replenish stores has not been determined so far. We therefore evaluated the efficacy and safety of intravenous sucrose as compared oral sulfate treatment deficiency anemia (IDA) IBD.A randomized, prospective, open-label, multicenter study was performed 46 transferrin saturation <or=20% and/or serum ferritin concentrations <or=20 microg/L. group received single...

10.1111/j.1572-0241.2005.00250.x article EN The American Journal of Gastroenterology 2005-09-12
Coming Soon ...